Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PCORI Forms Committee To Address Conflict Of Interest In Research

Executive Summary

Standing panel would review research grant applications for potential conflicts and advise the PCORI board. Transparency is stressed as a COI avoidance tool.

You may also be interested in...



PCORI In 2012: The Year Of Stakeholder Engagement

With a draft document containing the national priorities and research agenda now available for comment, PCORI will focus in 2012 on discussing with stakeholders what specific research should be funded. By the end of 2012 PCORI expects to have a portfolio of research activities under way.

PCORI To Seek Input On Areas Of Interest For Tier 1 Research Grants

The Patient-Centered Outcomes Research Institute’s Program Development Committee is eyeing Aug. 1 as the date it will begin the process for soliciting proposals for its “Tier 1” research grants.

FDA 2015 Budget Increase Proposal Leans On Food Safety User Fees

Food safety programs would get the largest increase in the White House’s proposed fiscal 2015 FDA budget, and increases in user fee programs are proposed as key drivers for the boost. The agency’s overall budget would grow $335 million to $4.7 billion in the proposal.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS053985

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel